Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 6/2017

01-12-2017 | Letter to the Editor

Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection

Reply to Drs. Ayubi and Safiri

Authors: Akira Kobayashi, Tsuyoshi Notake

Published in: International Journal of Clinical Oncology | Issue 6/2017

Login to get access

Excerpt

We appreciate the interest of Drs. Ayubi and Safiri in our study and their insightful comments [1]. We will be able to investigate the validity of our constructed model once the number of events increases in the future. We believe that their comments will help to improve the quality of our future studies greatly. …
Literature
1.
Ayubi E, Safiri S (2017) Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection: methodological issues. Int J Clin Oncol 22(4):803–804. doi:10.​1007/​s10147-017-1127-9 CrossRefPubMed
2.
Notake T, Kobayashi A, Shinkawa H, Kawahara T, Shimizu A, Yokoyama T, Hasegawa K, Kokudo N, Matsuyama Y, Makuuchi M, S-i Miyagawa (2017) Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection. Int J Clin Oncol 22(4):715–725. doi:10.​1007/​s10147-017-1114-1 CrossRefPubMed
Metadata
Title
Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection
Reply to Drs. Ayubi and Safiri
Authors
Akira Kobayashi
Tsuyoshi Notake
Publication date
01-12-2017
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 6/2017
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-017-1194-y

Other articles of this Issue 6/2017

International Journal of Clinical Oncology 6/2017 Go to the issue

Letter to the Editor

The insufficient prognostic power of stenosis in patients with esophageal cancer

Original Article

Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy

Original Article

Gemcitabine monotherapy in patients with heavily treated nasopharyngeal cancer: a case series

Original Article

Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis

Original Article

Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003)

Original Article

Comparison between chemoselection and definitive radiotherapy in patients with cervical esophageal squamous cell carcinoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits